EVERSEPT PARTNERS, L.P.

Adviser information for EVERSEPT PARTNERS, L.P. last updated from Form ADV on March 25th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 9
Investment Advisory/Research 4
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 7 $1.5B
Non-Discretionary 0 $0
Total 7 $1.5B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 7 $1.5B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 71

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-108771
SEC ERA File Number 801-108771
SEC CIK Numbers 1697013
SEC CRD Numbers 282358
Legal Entity Identifier 549300X2D2KLB2XLNK52

Principal Office

444 MADISON AVENUE
22ND FLOOR
NEW YORK
NY
United States
Monday - Friday, 9:00AM -5:00PM
Tel: 212-271-4200, Fax: None

Websites

Chief Compliance Officer

BALKIR ZIHNALI
CHIEF OPERATING OFFICER
444 MADISON AVENUE
22ND FLOOR
NEW YORK
NY
United States
Tel: 212-271-4200
(Full email address available in API data)

Regulatory Contact

RON ROSENSTRAUS
CHIEF FINANCIAL OFFICER
444 MADISON AVENUE
22ND FLOOR
NEW YORK
NY
United States
Tel: 212-271-4200
(Full email address available in API data)

Industry Affiliates

CHALKSTREAM CAPITAL GROUP, L.P. Other investment adviser, including financial plannersCommodity pool operator or commodity trading advisor
EVERSEPT GP II, LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
EVERSEPT GP III, LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
EVERSEPT GP, LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
EVERSEPT ELS MASTER FUND, L.P. Hedge Fund $50.4M $0.1M 7
EVERSEPT GENERATIONS FUND, L.P. Hedge Fund $249.3M $0.1M 26
EVERSEPT GLOBAL HEALTHCARE FUND, LP Hedge Fund $1,105.4M $0.1M 346

Control Persons

Name Type Entity Title Since Ownership
ZIHNALI, BALKIR, (NMN) Individual CHIEF COMPLIANCE OFFICER & CHIEF OPERATING OFFICER 03/2020 < 5%
MOGHTADERI, KAMRAN, (NMN) Individual MANAGING PRINCIPAL 09/2015 > 75%
EVERSEPT 1 LLC Domestic Entity MEMBER 11/2016 < 5%
MOGHTADERI, KAMRAN, (NMN) Individual EVERSEPT 1 LLC MANAGING MEMBER 11/2016 > 75%
ROSENSTRAUS, RON, AVI Individual CHIEF FINANCIAL OFFICER 01/2023 < 5%
SHAH, RISHI, RASESH Individual PRESIDENT 01/2023 < 5%

No. Employees, Historic

201002020202120222023202420255 on 3/30/20207 on 3/24/20219 on 3/28/20229 on 9/29/202214 on 3/24/20239 on 3/25/2024

RAUM, Historic

2B1B0202020212022202320242025992584140 on 3/30/20201457338410 on 3/24/20211842319563 on 3/28/20221842319563 on 9/29/20221671022000 on 3/24/20231482568000 on 3/25/2024

No. Clients, Historic

201002020202120222023202420257 on 3/30/202011 on 3/24/202110 on 3/28/202210 on 9/29/20227 on 3/24/20237 on 3/25/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
2SEVENTY BIO INC COMMON STOCK 4M 1M
ABSCI CORPORATION COM 1M 326K
AC IMMUNE SA SHS 396K 99K
AFFIMED N V ORDINARY SHS NEW 907K 166K
ALECTOR INC COM 2M 542K
AMARIN CORP PLC SPONS ADR NEW 3M 4M
ARCUTIS BIOTHERAPEUTICS INC COM 8M 838K
ARGENX SE SPONSORED ADR 15M 35K
AUTOLUS THERAPEUTICS PLC SPON ADS 2M 611K
AVANTOR INC COM 3M 125K
BIO-TECHNE CORP COM 39M 543K
BIOCRYST PHARMACEUTICALS INC COM 7M 1M
BROOKDALE SR LIVING INC COM 11M 2M
CELLDEX THERAPEUTICS INC NEW COM NEW 23M 633K
CENTENE CORP DEL COM 8M 116K
CEREVEL THERAPEUTICS HLDNG I COM 4M 110K
COMMUNITY HEALTH SYS INC NEW COM 27M 8M
CYTOKINETICS INC COM NEW 7M 127K
DANAHER CORPORATION COM 10M 41K
ELEVANCE HEALTH INC COM 8M 15K
ELI LILLY & CO COM 19M 21K
EVOLUS INC COM 6M 574K
FULCRUM THERAPEUTICS INC COM 948K 153K
G1 THERAPEUTICS INC COM 456K 200K
GOSSAMER BIO INC COM 5M 5M
GSK PLC SPONSORED ADR 134M 3M
GUARDANT HEALTH INC COM 3M 99K
HCA HEALTHCARE INC COM 44M 135K
HEALTHEQUITY INC COM 36M 414K
HUMANA INC COM 14M 38K
ICON PLC SHS 4M 13K
IMMUNOVANT INC COM 2M 93K
INFLARX NV COM 3M 2M
INSMED INC COM PAR $.01 77M 1M
INSPIRE MED SYS INC COM 71M 533K
IONIS PHARMACEUTICALS INC COM 22M 457K
IQVIA HLDGS INC COM 3M 12K
KARYOPHARM THERAPEUTICS INC COM 4M 5M
KURA ONCOLOGY INC COM 1M 72K
LIQUIDIA CORPORATION COM NEW 4M 374K
MANNKIND CORP COM NEW 12M 2M
MEREO BIOPHARMA GROUP PLC SPON ADS 2M 496K
MERUS N V COM 4M 66K
MOLINA HEALTHCARE INC COM 5M 18K
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 3M 72K
MYRIAD GENETICS INC COM 4M 182K
NATERA INC COM 127M 1M
NEVRO CORP COM 4M 499K
NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES 6M 330K
NOVO-NORDISK A S ADR 21M 147K
OSCAR HEALTH INC CL A 5M 311K
PROTAGONIST THERAPEUTICS INC COM 18M 506K
PUMA BIOTECHNOLOGY INC COM 4M 1M
REPLIGEN CORP COM 24M 194K
REVVITY INC COM 47M 452K
SERES THERAPEUTICS INC COM 303K 418K
SPDR SER TR S&P BIOTECH 9M 100K
STOKE THERAPEUTICS INC COM 828K 61K
SUTRO BIOPHARMA INC COM 5M 2M
SYNDAX PHARMACEUTICALS INC COM 74M 4M
TERNS PHARMACEUTICALS INC COM 2M 286K
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS 77M 5M
TOURMALINE BIO INC COM 3M 205K
TRAVERE THERAPEUTICS INC COM 9M 1M
UNITED THERAPEUTICS CORP DEL COM 75M 235K
VAXCYTE INC COM 7M 96K
VERA THERAPEUTICS INC CL A 74M 2M
VIATRIS INC COM 14M 1M
VIKING THERAPEUTICS INC COM 7M 138K
VIRIDIAN THERAPEUTICS INC COM 7M 567K
XOMA CORP DEL COM NEW 2M 92K
ZIMVIE INC COM 14M 768K
SPDR S&P 500 ETF TR TR UNIT 17M 31K
INVESCO QQQ TR UNIT SER 1 137M 286K